{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:12:43Z","timestamp":1788487963625,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"18","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00216-025-06249-5","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T03:46:47Z","timestamp":1764388007000},"page":"5871-5880","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A multiplex method for high-throughput quantification of conjugated saccharide in glycoconjugate vaccines"],"prefix":"10.1007","volume":"418","author":[{"given":"Giovanni","family":"Santostefano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Corrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Malzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Amendola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Berti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Di Bussolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2387-7780","authenticated-orcid":false,"given":"Riccardo","family":"De Ricco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"key":"6249_CR1","doi-asserted-by":"publisher","first-page":"v","DOI":"10.1016\/j.coi.2016.07.001","volume":"41","author":"R Rappuoli","year":"2016","unstructured":"Rappuoli R, De Gregorio E. Editorial overview: vaccines: novel technologies for vaccine development. Curr Opin Immunol. 2016;41:v\u2013vii.","journal-title":"Curr Opin Immunol"},{"key":"6249_CR2","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.1002\/ejoc.201100296","volume":"2011","author":"L Morelli","year":"2011","unstructured":"Morelli L, Poletti L, Lay L. Carbohydrates and immunology: synthetic oligosaccharide antigens for vaccine formulation. Eur J Org Chem. 2011;2011:5723\u201377 MICROREVIEW.","journal-title":"Eur J Org Chem"},{"issue":"9","key":"6249_CR3","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1080\/14760584.2019.1657012","volume":"18","author":"F Micoli","year":"2019","unstructured":"Micoli F, Del Bino L, Alfini R, Carboni F, Romano MR, Adamo R. Glycoconjugate vaccines: current approaches towards faster vaccine design. Expert Rev Vaccines. 2019;18(9):881\u201395.","journal-title":"Expert Rev Vaccines"},{"key":"6249_CR4","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat4615","author":"R Rappuoli","year":"2018","unstructured":"Rappuoli R. Glycoconjugate vaccines: principles and mechanisms. Sci Transl Med. 2018. https:\/\/doi.org\/10.1126\/scitranslmed.aat4615.","journal-title":"Sci Transl Med"},{"issue":"20","key":"6249_CR5","doi-asserted-by":"publisher","first-page":"15672","DOI":"10.1021\/acs.chemrev.2c00021","volume":"122","author":"L Del Bino","year":"2022","unstructured":"Del Bino L, Osterlid KE, Wu DY, Nonne F, Romano MR, Codee J, et al. Synthetic glycans to improve current glycoconjugate vaccines and fight antimicrobial resistance. Chem Rev. 2022;122(20):15672\u2013716.","journal-title":"Chem Rev"},{"issue":"1","key":"6249_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1073\/pnas.1819612116","volume":"116","author":"R Rappuoli","year":"2019","unstructured":"Rappuoli R, De Gregorio E, Costantino P. On the mechanisms of conjugate vaccines. Proc Natl Acad Sci U S A. 2019;116(1):14\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6249_CR7","doi-asserted-by":"publisher","unstructured":"Biemans R, Micoli F, Romano MR. Glycoconjugate vaccines, production and characterization. Recent Trends in Carbohydrate Chemistry. Volume 2: Synthesis and Biomedical Applications of Glycans and Glycoconjugates2020. p. 285\u2013313.\u00a0https:\/\/doi.org\/10.1016\/B978-0-12-820954-7.00008-6, https:\/\/www.sciencedirect.com\/science\/article\/pii\/B9780128209547000086.","DOI":"10.1016\/B978-0-12-820954-7.00008-6"},{"key":"6249_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8101521","author":"M Pizza","year":"2020","unstructured":"Pizza M, Bekkat-Berkani R, Rappuoli R. Vaccines against meningococcal diseases. Microorganisms. 2020. https:\/\/doi.org\/10.3390\/microorganisms8101521.","journal-title":"Microorganisms"},{"issue":"44","key":"6249_CR9","doi-asserted-by":"publisher","first-page":"39875","DOI":"10.1021\/acsomega.2c04013","volume":"7","author":"R De Ricco","year":"2022","unstructured":"De Ricco R, Rech F, Onnis V, Coccone SS, Scalia G, Marcozzi C, et al. Development of a new solid-phase extraction base method for free saccharide content estimation of meningococcal conjugate vaccines. ACS Omega. 2022;7(44):39875\u201383.","journal-title":"ACS Omega"},{"key":"6249_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13020167","author":"NJ Beresford","year":"2025","unstructured":"Beresford NJ, De Benedetto G, Lockyer K, Gao F, Burkin K, Lalwani K, et al. Further insights into the measurement of free polysaccharide in meningococcal conjugate vaccines. Vaccines. 2025. https:\/\/doi.org\/10.3390\/vaccines13020167.","journal-title":"Vaccines"},{"key":"6249_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.biologicals.2021.01.001","volume":"70","author":"F Gao","year":"2021","unstructured":"Gao F, Beresford N, Lockyer K, Burkin K, Rigsby P, Bolgiano B. Saccharide dosage content of meningococcal polysaccharide conjugate vaccines determined using WHO international standards for serogroup A, C, W, Y and X polysaccharides. Biologicals. 2021;70:53\u20138.","journal-title":"Biologicals"},{"issue":"11","key":"6249_CR12","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1021\/ac5003933","volume":"86","author":"SK Gudlavalleti","year":"2014","unstructured":"Gudlavalleti SK, Crawford EN, Harder JD, Reddy JR. Quantification of each serogroup polysaccharide of neisseria meningitidis in A\/C\/Y\/W-135-DT conjugate vaccine by high-performance anion-exchange chromatography-pulsed amperometric detection analysis. Anal Chem. 2014;86(11):5383\u201390.","journal-title":"Anal Chem"},{"issue":"36","key":"6249_CR13","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1016\/j.vaccine.2013.05.098","volume":"31","author":"MC Cook","year":"2013","unstructured":"Cook MC, Bliu A, Kunkel JP. Quantitation of serogroups in multivalent polysaccharide-based meningococcal vaccines: optimisation of hydrolysis conditions and chromatographic methods. Vaccine. 2013;31(36):3702\u201311.","journal-title":"Vaccine"},{"issue":"4","key":"6249_CR14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.biologicals.2013.03.003","volume":"41","author":"MC Cook","year":"2013","unstructured":"Cook MC, Gibeault S, Filippenko V, Ye Q, Wang J, Kunkel JP. Serogroup quantitation of multivalent polysaccharide and polysaccharide-conjugate meningococcal vaccines from China. Biologicals. 2013;41(4):261\u20138.","journal-title":"Biologicals"},{"key":"6249_CR15","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.4c04546","author":"G Santostefano","year":"2025","unstructured":"Santostefano G, Corrado A, Malzone C, Di Pietro S, Di Bussolo V, De Ricco R. Glycoconjugate vaccine quantification: an overview on present and future trends in analytical development. Anal Chem. 2025. https:\/\/doi.org\/10.1021\/acs.analchem.4c04546.","journal-title":"Anal Chem"},{"key":"6249_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.biologicals.2022.02.004","volume":"76","author":"F Rech","year":"2022","unstructured":"Rech F, De Ricco R, Giannini S, Nompari L, Paludi M, Berti S, et al. Glycoconjugate content quantification to assess vaccine potency: a simplified approach. Biologicals. 2022;76:10\u20134.","journal-title":"Biologicals"},{"key":"6249_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/978-1-0716-1186-9_16","volume":"2261","author":"C Cox","year":"2021","unstructured":"Cox C. Bead-based multiplex immunoassays: procedures, tips, and tricks. Methods Mol Biol. 2021;2261:263\u201376.","journal-title":"Methods Mol Biol"},{"issue":"2","key":"6249_CR18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00580-021-03302-4","volume":"31","author":"H Ahsan","year":"2022","unstructured":"Ahsan H. Monoplex and multiplex immunoassays: approval, advancements, and alternatives. Comp Clin Path. 2022;31(2):333\u201345.","journal-title":"Comp Clin Path"},{"key":"6249_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10080928","author":"B Bolgiano","year":"2021","unstructured":"Bolgiano B, Moran E, Beresford NJ, Gao F, Care R, Desai T, et al. Evaluation of critical quality attributes of a pentavalent (A, C, Y, W, X) meningococcal conjugate vaccine for global use. Pathogens. 2021. https:\/\/doi.org\/10.3390\/pathogens10080928.","journal-title":"Pathogens"},{"key":"6249_CR20","doi-asserted-by":"publisher","unstructured":"The Medical Letter I. Penmenvy \u2014 A Second Pentavalent Meningococcal Vaccine.\u00a0Med Lett Drugs Ther. 2025;67(1726):57\u20139. https:\/\/doi.org\/10.58347\/tml.2025.1726a.","DOI":"10.58347\/tml.2025.1726a"},{"key":"6249_CR21","unstructured":"Cytiva. Ab Buffer Kit Instructions 28903455 AD. Uppsala: Cytiva; 2020. Available from: https:\/\/cdn.cytivalifesciences.com\/api\/public\/content\/digi-15072-pdf."},{"key":"6249_CR22","unstructured":"Angeloni S, Das S, De Jager W, Dunbar S. xMAP\u00ae Cookbook 2013-2022. (xMAP\u00ae Cookbook|Diasorin)."},{"key":"6249_CR23","unstructured":"United States Food and Drug Administration. Bioanalytical Method Validation: Guidance for Industry. Silver Spring, MD: U.S. Department of Health and Human Services, Food and Drug Administration. 2018. https:\/\/www.fda.gov\/regulatory-information\/searchfda-guidance-documents\/bioanalytical-method-valid."},{"issue":"45","key":"6249_CR24","doi-asserted-by":"publisher","first-page":"6409","DOI":"10.1016\/j.vaccine.2012.08.021","volume":"30","author":"F Berti","year":"2012","unstructured":"Berti F, Romano MR, Micoli F, Pinto V, Cappelletti E, Gavini M, et al. Relative stability of meningococcal serogroup A and X polysaccharides. Vaccine. 2012;30(45):6409\u201315.","journal-title":"Vaccine"},{"issue":"2","key":"6249_CR25","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.vaccine.2014.11.026","volume":"33","author":"S Pecetta","year":"2015","unstructured":"Pecetta S, Lo Surdo P, Tontini M, Proietti D, Zambonelli C, Bottomley MJ, et al. Carrier priming with CRM 197 or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: biophysical and immunochemical interpretation. Vaccine. 2015;33(2):314\u201320.","journal-title":"Vaccine"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-025-06249-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00216-025-06249-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-025-06249-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:23:21Z","timestamp":1788485001000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00216-025-06249-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":25,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["6249"],"URL":"https:\/\/doi.org\/10.1007\/s00216-025-06249-5","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"12 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Alessio Corrado, Carmine Malzone, Diego Amendola, Leonardo Mori, Stefania Berti, and Riccardo De Ricco are employees of the GSK group of companies. Giovanni Santostefano is a PhD student from the University of Pisa and participates in a post graduate studentship program at GSK. Valeria Di Bussolo is a Professor at the University of Pisa and declares no conflict of interest. This work was sponsored by GlaxoSmithKline Biologicals SA. The sponsor was involved in all stages of the study conduct and analysis. General trademark statements: Menveo is a registered trademark owned by or licensed to the GSK group of companies. MenQuadfi is a registered trademark of Sanofi Pasteur Inc.. Nimenrix is a registered trademark of the GSK group of companies, licensed to Pfizer Inc.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}